OncoDaily IO路 @OncoDailyIO 路 X路路 20 hours agoScore70
Body
馃К EMERALD-3 exploratory analysis in HCC:
Mean liver function scores remained stable during treatment with STRIDE 卤 lenvatinib + TACE.
Survival estimates generally favored the combinations, but a definitive OS benefit remains unproven.
https://oncodaily.com/oncolibrary/immune-oncology/emerald-3-trial-esmo
#ESMO2026 #OncoDaily #EMERALD3
14 views 路 1 like 路 0 reposts 路 0 replies
Source: OncoDaily IO 路 x.com